[go: up one dir, main page]

CL2008003845A1 - Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. - Google Patents

Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.

Info

Publication number
CL2008003845A1
CL2008003845A1 CL2008003845A CL2008003845A CL2008003845A1 CL 2008003845 A1 CL2008003845 A1 CL 2008003845A1 CL 2008003845 A CL2008003845 A CL 2008003845A CL 2008003845 A CL2008003845 A CL 2008003845A CL 2008003845 A1 CL2008003845 A1 CL 2008003845A1
Authority
CL
Chile
Prior art keywords
bacterin
vaccine
viruses
emulsion
species
Prior art date
Application number
CL2008003845A
Other languages
English (en)
Inventor
Mark Davis Goodyear
Michael John Huether
Richard Lee Krebs
Nancee L Oien
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40514058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003845(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of CL2008003845A1 publication Critical patent/CL2008003845A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN BACTERINAS TRATADAS TÉRMICAMENTE, UN PROCEDIMIENTO PARA PRODUCIR BACTERINAS TRATADAS TÉRMICAMENTE Y VACUNAS DE EMULSIÓN PORCINAS PREPARADAS A PARTIR DE TALES BACTERINAS TRATADAS TÉRMICAMENTE.
CL2008003845A 2007-12-21 2008-12-19 Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. CL2008003845A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1571807P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
CL2008003845A1 true CL2008003845A1 (es) 2010-09-24

Family

ID=40514058

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003845A CL2008003845A1 (es) 2007-12-21 2008-12-19 Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.

Country Status (21)

Country Link
US (2) US20090162397A1 (es)
EP (1) EP2224951B1 (es)
JP (2) JP5890096B2 (es)
KR (1) KR101254848B1 (es)
CN (2) CN101903041A (es)
AR (1) AR070675A1 (es)
AU (1) AU2008348022B2 (es)
BR (1) BRPI0819938B1 (es)
CA (1) CA2710186C (es)
CL (1) CL2008003845A1 (es)
CO (1) CO6290700A2 (es)
DK (1) DK2224951T3 (es)
ES (1) ES2763395T3 (es)
LT (1) LT2224951T (es)
NZ (1) NZ585877A (es)
PT (1) PT2224951T (es)
RU (1) RU2440137C1 (es)
TW (1) TWI419702B (es)
UY (1) UY31557A1 (es)
WO (1) WO2009090461A1 (es)
ZA (1) ZA201005178B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008348022B2 (en) * 2007-12-21 2015-03-05 Zoetis Services Llc Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
CN108578679A (zh) * 2012-08-30 2018-09-28 梅里亚有限公司 嵌合ksac蛋白的表达和由高压产生可溶性蛋白的方法
WO2014151401A1 (en) 2013-03-15 2014-09-25 Zoetis Llc CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE
CN105879023B (zh) * 2016-05-28 2020-11-27 青岛易邦生物工程有限公司 一种猪细小病毒和猪流行性腹泻二联灭活疫苗
CN106039304B (zh) * 2016-05-28 2021-02-05 青岛易邦生物工程有限公司 一种猪细小病毒、猪流行性腹泻、大肠埃希氏菌三联疫苗
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN111658611B (zh) * 2020-04-13 2021-06-01 四川大学 一种基于微乳的疫苗递送系统及其制备方法和应用
CN112941091A (zh) * 2021-03-17 2021-06-11 吉林大学 一种猪血凝性脑脊髓炎dna疫苗及其制备方法
WO2024235705A1 (en) * 2023-05-12 2024-11-21 Intervet International B.V. A combination vaccine against erysipelothrix rhusiopathiae, porcine parvo virus and leptospira bacterium
WO2024235714A1 (en) * 2023-05-12 2024-11-21 Intervet International B.V. A vaccine against leptospira bacterium
WO2024235713A1 (en) * 2023-05-12 2024-11-21 Intervet International B.V. A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
KR20050062542A (ko) * 2002-08-26 2005-06-23 화이자 프로덕츠 인코포레이티드 소의 호흡기 및 생식기계 감염에 대한 백신
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
MXPA05010697A (es) * 2003-04-04 2005-12-12 Pfizer Prod Inc Emulsiones de aceite en agua microfluidizadas y composiciones de vacunas.
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
RS51996B (sr) * 2005-09-16 2012-04-30 Merial Ltd. Stabilizatori za vakcine osušene zamrzavanjem
PL2275132T3 (pl) * 2005-12-29 2021-09-13 Boehringer Ingelheim Animal Health USA Inc. Multiwalentne immunogenne kompozycje PCV2 i sposoby ich wytwarzania
MX2009001849A (es) * 2006-09-11 2009-03-02 Pfizer Prod Inc Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor.
US20100233204A1 (en) * 2007-02-27 2010-09-16 Wyeth Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
AU2008348022B2 (en) * 2007-12-21 2015-03-05 Zoetis Services Llc Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Also Published As

Publication number Publication date
TW200940088A (en) 2009-10-01
ES2763395T3 (es) 2020-05-28
CN106562927A (zh) 2017-04-19
CA2710186C (en) 2015-11-03
LT2224951T (lt) 2020-01-10
EP2224951B1 (en) 2019-10-30
JP5890096B2 (ja) 2016-03-22
AR070675A1 (es) 2010-04-28
DK2224951T3 (da) 2020-01-06
JP2011507827A (ja) 2011-03-10
US20100285057A1 (en) 2010-11-11
JP2014237698A (ja) 2014-12-18
WO2009090461A1 (en) 2009-07-23
CA2710186A1 (en) 2009-07-23
UY31557A1 (es) 2009-08-03
KR101254848B1 (ko) 2013-04-15
NZ585877A (en) 2012-06-29
TWI419702B (zh) 2013-12-21
CO6290700A2 (es) 2011-06-20
CN101903041A (zh) 2010-12-01
AU2008348022B2 (en) 2015-03-05
RU2440137C1 (ru) 2012-01-20
PT2224951T (pt) 2020-01-10
KR20100092022A (ko) 2010-08-19
BRPI0819938A2 (pt) 2015-05-26
BRPI0819938B1 (pt) 2019-02-26
US20090162397A1 (en) 2009-06-25
ZA201005178B (en) 2011-03-30
US9289482B2 (en) 2016-03-22
AU2008348022A1 (en) 2009-07-23
EP2224951A1 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
MX2008009929A (es) Vacuna a base de levadura para inducir una respuesta inmune.
EA201070794A1 (ru) Рекомбинантные антигены rsv
WO2016007576A3 (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
MX388128B (es) Vacuna combinada para cerdos.
CO2019011548A2 (es) Vacunas contra el gallid herpesvirus 3 recombinante que codifican antígenos patogénicos aviares heterólogos
MX2009006178A (es) Vacuna contra salmonela.
BRPI0816134A2 (pt) Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença.
BR112012016048A2 (pt) "exossomas derivados de reticulócitos infectados com plasmodium sp., método para obter os mesmos e usos dos mesmos".
CO6260102A2 (es) Cepas de mycoplasma gallisepticum atenuadas
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
UA110505C2 (ru) Імуногенні композиції bordetella bronchiseptica
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
RU2018127403A (ru) Поливалентная вакцина против hyo и ее применение
RU2016109366A (ru) Назальная мукозальная вакцинная композиция
DK1796717T3 (da) Kombinationsvaccine
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
AR062758A1 (es) Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor
CL2020002876A1 (es) Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420)
RU2013135887A (ru) Композиции для комплекса респираторных заболеваний собак
BR112012022680A2 (pt) métodos para proteger um animal um canino contra doença, e, uso de uma vacina contra vírus da influenza canina
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76
BRPI0819031A2 (pt) processo para preparar cepas virais atenuadas, vírus atenuado, uso de uma cepa viral atenuada e vacina baseada em vírus atenuado vivos.